Ikena Oncology, Inc.IKNANASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank43
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-47.84M
↓ 22% vs avg
Percentile
P43
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-39.31M
Historical baseline
PeriodValueYoY Change
2025$-47.84M-4.0%
2024$-46.00M+42.6%
2023$-80.16M-6.1%
2022$-75.54M-21.8%
2021$-62.01M-60.7%
2020$-38.59M-181.1%
2019$47.61M+499.7%
2018$-11.91M-